Synapse: Law for Life Sciences





Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Countdown to the UPC - watch the recording
Entering into commercial agreements
Patent Transactions in the Life Sciences
Subscribe to Synapse

This month on Synapse: EMA adopts policy on publication of clinical trial data


Diana Heimhalt discusses the European Medicines Agency's new approach to the publication of clinical reports, including the new terms of use and process for redactions to protect commercially confidential information.



arrowView our previous articles

Topical Issues


Clarification on the meaning of "specified"/"identified" for SPC protection
Matthew Royle and Paul England report on the UK first instance decision in Eli Lilly v HGS (following the CJEU ruling), which attempts to clarify the approach to be taken.... read more


The Nagoya Protocol
Steffen Wirsing explores the problem of biopiracy and the proposed solution in the Nagoya Protocol, which aims to prevent the exploitation of resources and knowledge... read more


Keeping your confidential information and staff safe from competitors
Stephanie Creed explains the problems encountered by life sciences businesses when trying to restrict access to and use of information by more

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here